Jianqing Li

10PUBLICATIONS
32CO-AUTHORS
Biologically active moleculesMolecular targetsMolecular medicineOrganometallic chemistryBiocatalysis and enzyme technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 22, 2022
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4.

E Scott Priestley, Jacques Banville, Daniel Deon

|Sep 08, 2021
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy.

Andrew K Dilger, Kumar B Pabbisetty, James R Corte

|Dec 28, 2020
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.

Chunjian Liu, James Lin, Charles Langevine

Pageof 2